Experimental antibiotic treatment for Lyme disease heads for human safety trials

Human safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart